1. Home
  2. UK vs DRMA Comparison

UK vs DRMA Comparison

Compare UK & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UK
  • DRMA
  • Stock Information
  • Founded
  • UK 2015
  • DRMA 2014
  • Country
  • UK China
  • DRMA United States
  • Employees
  • UK N/A
  • DRMA N/A
  • Industry
  • UK Business Services
  • DRMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • UK Consumer Discretionary
  • DRMA Health Care
  • Exchange
  • UK Nasdaq
  • DRMA Nasdaq
  • Market Cap
  • UK 1.8M
  • DRMA 1.7M
  • IPO Year
  • UK N/A
  • DRMA 2021
  • Fundamental
  • Price
  • UK $1.23
  • DRMA $1.14
  • Analyst Decision
  • UK
  • DRMA Strong Buy
  • Analyst Count
  • UK 0
  • DRMA 1
  • Target Price
  • UK N/A
  • DRMA $6.00
  • AVG Volume (30 Days)
  • UK 67.4K
  • DRMA 89.0K
  • Earning Date
  • UK 12-03-2024
  • DRMA 11-13-2024
  • Dividend Yield
  • UK N/A
  • DRMA N/A
  • EPS Growth
  • UK N/A
  • DRMA N/A
  • EPS
  • UK N/A
  • DRMA N/A
  • Revenue
  • UK $42,470,655.00
  • DRMA N/A
  • Revenue This Year
  • UK N/A
  • DRMA N/A
  • Revenue Next Year
  • UK N/A
  • DRMA N/A
  • P/E Ratio
  • UK N/A
  • DRMA N/A
  • Revenue Growth
  • UK N/A
  • DRMA N/A
  • 52 Week Low
  • UK $1.12
  • DRMA $1.05
  • 52 Week High
  • UK $6.85
  • DRMA $13.35
  • Technical
  • Relative Strength Index (RSI)
  • UK 46.87
  • DRMA 38.60
  • Support Level
  • UK $1.18
  • DRMA $1.07
  • Resistance Level
  • UK $1.27
  • DRMA $1.45
  • Average True Range (ATR)
  • UK 0.07
  • DRMA 0.13
  • MACD
  • UK 0.00
  • DRMA -0.01
  • Stochastic Oscillator
  • UK 53.33
  • DRMA 17.78

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. They provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has three operating segments: Workspace membership, Marketing and branding services, and Other services. Marketing and branding services generate the majority of the company's revenue.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

Share on Social Networks: